Mosedipimod

View All

Chemotherapy Induced Febrile Neutropenia Market
Chemotherapy Induced Febrile Neutropenia Market: High time to end the monopoly

A rich pipeline in the Chemotherapy Induced Febrile Neutropenia market with promising clinical pieces of evidence, CIFN market size is expected to increase drastically by 2030 A range of breakthroughs and series of medical advancements have significantly helped in dampening down the global burden of cancer, wh...

Find More

Meeting the Unmet Need for Oral Mucositis

Oral Mucositis (OM) refers to erythematous and ulcerative lesions of the oral mucosa observed in cancer patients under chemotherapy or radiation therapy. In its severe form, OM presents as confluent, deep ulcerations. Typical manifestations are atrophy, erythema, ulceration, and swelling of the mucosa. It appears fi...

Find More